Readmission Risk in Chronic Obstructive Pulmonary Disease Patients: Comparative Study of Nebulized β2-Agonists
Crossref DOI link: https://doi.org/10.1007/s40801-016-0097-y
Published Online: 2016-11-18
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bollu, Vamsi
Guérin, Annie
Gauthier, Geneviève
Hiscock, Robert
Wu, Eric Q.
License valid from 2016-11-18